Study Design Analyst – Evinova China
è·ä½æè¿°
At Evinova, we put patients first and strive to meet their unmet needs worldwide. Working here means being entrepreneurial, thinking big, and working together to make the impossible a reality. If you are swift to action, confident to lead, willing to collaborate, and curious about what science can do, then you’re our kind of person.Evinova is a health-tech business, separate company within the AstraZeneca Group, accelerating the delivery of better health outcomes by propelling the life sciences sector forward in digital health, from the inside. Through our application of science-based expertise, evidence-led rigor, and human experience-driven insight, our digital solutions are deliberately crafted so that everyone can reach better health outcomes together.In this role on our Solution Delivery team, you’ll lead the design and deployment of Evinova’s platform for clinical trials. You’ll translate complex clinical protocols into system configuration, manage the design process, and ensure the successful implementation of our Unified Trial Platform. Your expertise will shape the future of clinical studies, making healthcare more efficient and accessible.Key Responsibilities:Study Implementation ◠Lead the design and configuration of Unified Trial Platform, ensuring clinical protocols are effectively translated into system configuration. ◠Be consultative with the sponsor team, serving as a domain expert on our digital solution and providing insights into the system capabilities, configuration options and practical application of its features in a clinical trial. ◠Lead the overall study configuration and design process, implementing design best practices and using reusable assets such as eCOA libraries and translations. ◠Be a close partner with internal and external partners with respect to translations, assessment licensing, integration, validation and quality control.Pre- and Post-Implementation ◠Support the team on assessing upcoming clinical trials, consulting on solutions and delivery methods that best meet the study’s needs. ◠Conduct risk assessment and impact analysis of new software releases, upgrades and changes ◠Provide ongoing support and guidance to clinical trial and implementation teams during the deployment and post-implementation phases including addressing issues and implementing improvements as needed.Essential Requirements: ◠Bachelor’s degree in relevant information technology, life science or related field preferred. ◠4-7 years of experience in building and configuring digital solutions for clinical trials; 3 years of experience specifically with eCOA systems. ◠Proven senior stakeholder management skills, including negotiation, collaboration, and interpersonal leadership abilities, coupled with the ability to work collaboratively in a cross-functional setting with both internal and external partners. ◠Demonstrable experience of gathering and translating business requirements into technical specifications and configurations for digital solutions used in clinical trials. ◠Strong understanding of clinical trial processes and regulations with respect to study design. ◠Experience with connected devices (e.g. PEF, oxygen monitors) and integrating with other clinical systems, such as IVRS, EDC, data lakes, etc. ◠Excellent analytical, problem-solving, and communication skills with the ability to interact effectively with team members and customers at all levels. ◠Excellent discernment and insights with sensitivity to environment. ◠Strong learning capability and passion to digital clinical research. ◠Fluent English and Mandarin, both can be used as working language.Desirable Requirements: ◠Master degree in relevant discipline. ◠Experience from Healthcare and Life Sciences, preferably with clinical trials. ◠Experience of working in a global organization with complex/geographical context. ◠Experience of working in a regulated environment, ideally of delivering GxP and SaMD solutions.Why Evinova (AstraZeneca)?Evinova draws on AstraZeneca’s deep experience developing novel therapeutics, informed by insights from thousands of patients and clinical researchers. Together, we can accelerate the delivery of life-changing medicines, improve the design and delivery of clinical trials for better patient experiences and outcomes, and think more holistically about patient care before, during, and after treatment. We know that regulators, healthcare professionals, and care teams at clinical trial sites do not want a fragmented approach. They do not want a future where every pharmaceutical company provides its own, different digital solutions. They want solutions that work across the sector, simplify their workload, and benefit patients broadly. By bringing our solutions to the wider healthcare community, we can help build more unified approaches to how we all develop and deploy digital technologies, better serving our teams, physicians, and ultimately patients. Evinova represents a unique opportunity to deliver meaningful outcomes with digital and AI to serve the wider healthcare community and create new standards for the sector. Join us on our journey of building a new kind of health tech business to reset expectations of what a bio-pharmaceutical company can be. This means we’re opening new ways to work, pioneering innovative methods, and bringing unexpected teams together.Location: Shanghai ChinaSalary: Competitive + Excellent Benefits!So, what’s next?Are you already imagining yourself joining our team? Good, because we can’t wait to hear from you.Where can I find out more?Our Social Media, Follow Evinova on LinkedIn Learn more about Evinova
伿¥(yè)簡介
阿斯利康是全çƒé ˜å…ˆåˆ¶è—¥å…¬å¸ï¼Œç”±å‰ç‘žå…¸é˜¿æ–¯ç‰¹æ‹‰å…¬å¸å’Œå‰è‹±åœ‹æ·åˆ©åº·å…¬å¸äºŽ1999å¹´åˆå¹¶è€Œæˆã€‚阿斯利康在6å¤§æ²»ç™‚é ˜åŸŸç‚ºæ‚£è€…æä¾›å¯ŒäºŽå‰µ(chuà ng)æ–°ï¼Œå“æœ‰æˆæ•ˆçš„醫(yÄ«)藥產(chÇŽn)å“,包括消化ã€å¿ƒè¡€ç®¡ã€è…«ç˜¤ã€ä¸æ¨žç¥žç¶“(jÄ«ng)ã€éº»é†‰å’Œå‘¼å¸ç‰ï¼Œå…¶ä¸è¨±å¤šç”¢(chÇŽn)å“å±…äºŽä¸–ç•Œé ˜å…ˆåœ°ä½ã€‚
阿斯利康總部ä½äºŽè‹±åœ‹å€«æ•¦ï¼Œç ”發(fÄ)總部ä½äºŽç‘žå…¸ã€‚產(chÇŽn)å“銷售覆蓋全çƒ100多個國家和地å€(qÅ«)。2005å¹´å…¬å¸éŠ·å”®æ”¶å…¥ç‚º240億美元。
é˜¿æ–¯åˆ©åº·æ“æœ‰å¼·å¤§çš„ç ”ç™¼(fÄ)èƒ½åŠ›ï¼Œå¹³å‡æ¯å€‹å·¥ä½œæ—¥çš„ç ”ç™¼(fÄ)投入é”到1400è¬ç¾Žå…ƒ (2005å¹´ç ”ç™¼(fÄ)總投入為34億美元)。我們在7å€‹åœ‹å®¶è¨æœ‰11å€‹ç ”ç™¼(fÄ)機構,共有11,900åå“¡å·¥å¾žäº‹èˆ‡æ–°è—¥ç ”ç™¼(fÄ)相關的工作。
é˜¿æ–¯åˆ©åº·æ“æœ‰æ¥µå…·å¸Œæœ›çš„æ—©æœŸé–‹ç™¼(fÄ)產(chÇŽn)å“組åˆï¼Œå…±æœ‰45å€‹é …ç›®è™•äºŽè‡¨åºŠå‰ç ”究階段ã€17å€‹é …ç›®è™•äºŽä¸€æœŸè‡¨åºŠç ”ç©¶éšŽæ®µã€13å€‹é …ç›®è™•äºŽäºŒæœŸè‡¨åºŠç ”ç©¶éšŽæ®µã€6å€‹é …ç›®è™•äºŽä¸‰æœŸè‡¨åºŠç ”ç©¶éšŽæ®µã€‚
阿斯利康在全çƒ19個國家有27個生產(chÇŽn)基地,共有14,000å員工致力于為客戶æä¾›å®‰å…¨ã€æœ‰æ•ˆã€é«˜è³ª(zhì)é‡çš„產(chÇŽn)å“。
阿斯利康在全çƒå…±æœ‰65,000å員工,從事醫(yÄ«)藥產(chÇŽn)å“和醫(yÄ«)療æœå‹™çš„ç ”ç™¼(fÄ)ã€ç”Ÿç”¢(chÇŽn)和銷售æ¥(yè)務。
阿斯利康被列入é“ç“Šæ–¯å¯æŒçºŒ(xù)發(fÄ)展指數(shù)(全çƒï¼‰ä»¥åŠé¡¯ç¤ºä¼æ¥(yè)良好社會責任度的富時社會責任指數(shù)(FTSE4Good Index)。
è·ä½ç™¼(fÄ)å¸ƒä¼æ¥(yè)

阿斯利康制藥公å¸
伿¥(yè)性質(zhì):
伿¥(yè)è¦(guÄ«)模:1-49人
æˆç«‹å¹´ä»½ï¼š
伿¥(yè)ç¶²(wÇŽng)å€ï¼šhttp://www.chnequestrian.com
伿¥(yè)地å€ï¼šæµ·æ·€å€(qÅ«)
è©²ä¼æ¥(yè)å…¶ä»–è·ä½æ›´å¤š>>
- é¢è° Translational Medicine Operation Asso. Manager
- é¢è° 醫(yÄ«)藥代表(é”州市宣漢+大足)
- é¢è° 醫(yÄ«)藥代表
- é¢è° 醫(yÄ«)藥代表(常德)
- é¢è° 醫(yÄ«)藥代表(淮å—)
- é¢è° 醫(yÄ«)藥代表(邢臺)
- é¢è° 醫(yÄ«)å¸ä»£è¡¨-肺癌產(chÇŽn)å“-江蘇
- é¢è° 醫(yÄ«)å¸ä»£è¡¨-肺癌產(chÇŽn)å“-å±±æ±
- é¢è° 醫(yÄ«)å¸ä»£è¡¨-肺癌產(chÇŽn)å“-å±±æ±
- é¢è° 醫(yÄ«)å¸ä»£è¡¨-肺癌產(chÇŽn)å“-å±±æ±